Intellectia LogoIntellectia
Stock
Crypto
Features
Resources
Company
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo
StockCrypto

Features

AI Stock Picker
Financial AI Agent
Swing Trading
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
Stock Chart Patterns
Earnings Trading
AI Screener

Resources

Resources

Blog
Earnings
Partner Program

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Company

Contact
About
News Release
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. BMRN
    4. >
  4. Valuation

Valuation

-
stocks logo
BMRN
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is BMRN Overvalued？

BMRN is now in the zone, suggesting that BMRN current forward PE ratio of 17.28 is considered compare with the five-year average of 50.32.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

BMRN Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
BMRN.O
Biomarin Pharmaceutical Inc
38.38
Average P/E: 102.13
159.16%
12.10B
stocks logo
MRNA.O
Moderna Inc
loss
Average P/E: 102.13
100.34%
12.26B
stocks logo
TECH.O
Bio-Techne Corp
74.32
Average P/E: 102.13
26.59%
11.05B
stocks logo
PCVX.O
Vaxcyte Inc
loss
Average P/E: 102.13
8.53%
10.71B
stocks logo
TLX.O
Telix Pharmaceuticals Ltd
193.70
Average P/E: 102.13
6.09B
stocks logo
SMMT.O
Summit Therapeutics Inc
loss
Average P/E: 102.13
-153.97%
15.12B

BMRN Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

BMRN FAQs

Is BMRN currently overvalued based on its P/E ratio?

According to the provided data, BMRN's 5-year historical average forward P/E ratio is 50.33. BMRN forward P/E ratio is 17.28, which is categorized as Undervalued.

How has BMRN's P/E ratio changed over the quarters?

The P/E ratio has shown significant fluctuations, with a notable decrease from 62.24 to 42.13, indicating changes in market expectations and earnings.

What is the significance of the EV/EBITDA ratio for BMRN?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has BMRN's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 6.20 to 5.01, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for BMRN's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

BMRN PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
50.32
Current PE
17.28
Overvalued PE
75.20
Undervalued PE
25.45

BMRN EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
86.83
Current EV
15.52
Overvalued EV
206.17
Undervalued EV
-32.52

BMRN P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
7.13
Current PS
4.10
Overvalued PS
8.66
Undervalued PS
5.60

BMRN Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
BMRN.O
Biomarin Pharmaceutical Inc
38.38
Average P/E: 102.13
159.16%
12.10B
stocks logo
MRNA.O
Moderna Inc
loss
Average P/E: 102.13
100.34%
12.26B
stocks logo
TECH.O
Bio-Techne Corp
74.32
Average P/E: 102.13
26.59%
11.05B
stocks logo
PCVX.O
Vaxcyte Inc
loss
Average P/E: 102.13
8.53%
10.71B
stocks logo
TLX.O
Telix Pharmaceuticals Ltd
193.70
Average P/E: 102.13
6.09B
stocks logo
SMMT.O
Summit Therapeutics Inc
loss
Average P/E: 102.13
-153.97%
15.12B

BMRN Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is BMRN undervalued？Is BMRN overvalued compared to its competitors？

BMRN FAQs

Is BMRN currently overvalued based on its P/E ratio?

According to the provided data, BMRN's 5-year historical average forward P/E ratio is 50.33. BMRN forward P/E ratio is 17.28, which is categorized as Undervalued.

How has BMRN's P/E ratio changed over the quarters?

The P/E ratio has shown significant fluctuations, with a notable decrease from 62.24 to 42.13, indicating changes in market expectations and earnings.

What is the significance of the EV/EBITDA ratio for BMRN?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has BMRN's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 6.20 to 5.01, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for BMRN's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is BMRN undervalued？Is BMRN overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Product
AI Stock PickerFinancial AI AgentSwing TradingStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisStock Chart PatternsEarnings TradingAI Screener
Support
BlogEarningsTerms of UsePrivacy PolicySitemapPartner Program
Start for Free